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Abstract 
Thermoresponsive polymeric platforms are used to optimise drug delivery in pharmaceutical 
systems and bioactive medical devices.  However, the practical application of these systems 
is compromised by their poor mechanical properties. This study describes the design of 
thermoresponsive semi-interpenetrating polymer networks (s-IPNs) based on cross-linked 
p(NIPAA) or p(NIPAA-co-HEMA) hydrogels containing poly(ε-caprolactone) designed to 
address this issue.  Using DSC, the lower critical solution temperature of the co-polymer and 
p(NIPAA) matrices were circa 34oC and 32oC, respectively.  PCL was physically dispersed 
within the hydrogel matrices as confirmed using confocal scanning laser microscopy and DSC 
and resulted in marked changes in the mechanical properties (Ultimate tensile strength, 
Young’s modulus) without adversely compromising the elongation properties.  P(NIPAA) 
networks containing dispersed PCL exhibited thermoresponsive swelling properties 
following immersion in buffer (pH 7), with the equilibrium-swelling ratio being greater at 
20oC than 37oC and greatest for p(NIPAA)/PCL systems at 20oC.  The incorporation of PCL 
significantly lowered the equilibrium swelling ratio of the various networks but this was not 
deemed practically significant for s-IPNs based on p(NIPAA).  Thermoresponsive release of 
metronidazole was observed from s-IPN composed of p(NIPAA)/PCL at 37oC but not from 
p(NIPAA-co-HEMA)/PCL at this temperature.  In all other platforms drug release at 20oC was 
significantly similar to that at 37oC and was diffusion controlled.  This study has uniquely 
described a strategy by which thermoresponsive drug release may be performed from 
polymeric platforms with highly elastic properties.  It is proposed that these materials may 
be used clinically as bioactive endotracheal tubes, designed to offer enhanced resistance to 
ventilator associated pneumonia, a clinical condition associated with the use of 
endotracheal tubes where stimulus responsive drug release from biomaterials of significant 
mechanical properties would be advantageous. 
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1. Introduction 
Hydrogels are conveniently described as water swollen polymeric materials that retain their 
mechanical and topological structure in the swollen state.  The resultant properties of the 
hydrogels are dependent on several key parameters including the hydrophilicity of the 
polymer chains and the degree of cross-linking [1].  Hydrogels may be produced from a wide 
range of materials (both natural and synthetic) and may be synthesised to offer a wide range 
of properties that are relevant to drug delivery and medical device design [2].  Key to their 
use as biomaterials is their high water content as this enhances biocompatibility. At 
equilibrium, hydrogels may contain from 10 to 98% of water within their polymeric structure 
[3] although Lydon et al. [4] defined a lower limit of 20% absorbed weight of water.  Both 
the polymer crosslink density and the degree of hydrophilicity of the polymer govern the 
extent of polymeric swelling.  For this reason (and in addition to their flexibility) hydrogels 
have been used as contact lenses and urethral catheter coatings for several decades [5-7].   
 
Hydrogels have been successfully employed for the delivery of bioactive agents [8, 9].  For 
example, hydrogel-coated catheters have been loaded with antimicrobial agents, their 
subsequent release being associated with reduced medical device related infection [1, 8].  
Similarly, hydrogels have been used as the platform for the release of anticancer drugs [10].  
Drug release from hydrogels is dependent on the physicochemical properties of the drug 
and the hydrogel and, in addition, the degree of cross-linking [1].  However, in many cases, 
the release kinetics are inappropriate for the desired application.  For example, when used 
as medical device coatings, it is necessary that the hydrogels contain sufficient water to aid 
insertion and to maintain comfort in use, however, drug release from such systems is 
frequently rapid; thereby limiting their resistance to medical device related infection when 
implanted for longer durations.  To optimise their clinical performance, hydrogels have been 
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designed in which drug release is mediated by external stimuli [11], e.g. pH [12, 13], applied 
magnetic or electrical fields [14, 15], ultrasound [16], enzymatic action and/or light [17].  
Hydrogels, primarily based on poly(N-isopropyl acrylamide), have been designed to respond 
to temperature as an external stimulus.  In such systems a change in the phase of the 
polymer occurs at a defined temperature, referred to as the Lower Critical Solution 
Temperature (LCST) [18, 19].    Below the LCST, the hydrophilic nature of this polymer 
facilitates water uptake whereas above the LCST, hydrophobic interactions between the 
polymer chains result in a collapse of the three-dimensional hydrogel structure and the 
resultant “responsive” release of drug.  Several biological applications for this polymer have 
been cited including, cell grafting [18], gene delivery [20] and drug delivery [21, 22].   
 
The compromised mechanical properties of hydrogels often limit the scope of their 
applications within medicine [23].  For example, the poor mechanical properties (low 
ultimate tensile strength, low Young’s modulus) limit their use to coatings of medical 
devices, however, despite this, problems in use, e.g. delamination, fracture upon the 
application of normal stresses, may occur.  The mechanical properties of hydrogels may be 
improved by copolymerisation [19], improving crosslink density [1, 24] and using 
composites, however, whilst incremental improvements have been reported, these 
strategies are associated with associated disadvantages including modification of the 
equilibrium water content and adverse modification of drug release profiles. P(NIPAA) 
hydrogels have been previously reported to possess poor mechanical properties, which have 
in turn limited their thermoresponsive properties and their potential clinical applications 
[19, 25].  For example, copolymerisation of NIPAA with acrylate monomers has been 
reported to enhance the mechanical properties but adversely affect the thermoresponsive 
properties [19].  Enhancing the crosslink density of p(NIPAA) hydrogels decreases the 
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temperature dependent volume change of the polymer, which in turn affect water uptake 
and the degree of thermoresponsive behaviour. Therefore, strategies are needed to address 
this deficiency to ensure that hydrogels are developed that offer optimal drug release, 
equilibrium water content and mechanical properties.   
 
Within this landscape, this study presents a novel strategy to address this deficiency in which 
the mechanical properties of thermoresponsive hydrogels may be engineered by the 
formation of a semi-interpenetrating polymer network (s-IPN) with poly(ε-caprolactone) 
without the attendant loss of thermoresponsive drug release.  It is suggested that the 
approach presented in this study would be of considerable benefit for drug delivery 
systems/bioactive devices in which stimulus-responsive release is required from 
mechanically robust platforms, e.g. medical implants.  In particular, it is proposed that these 
systems may be employed as bioactive biomaterials for use as endotracheal tubes, designed 
to reduce mortality associated with ventilator associated pneumonia [26].  In particular drug 
loading of these systems may be performed by nebulisation of solutions of antimicrobial 
agents at temperatures below the lower critical solution temperature whereas, release, 
facilitated by mechanical changes to the network, will occur at temperatures above the 
lower critical solution temperature.  The thermal stimulus may be achieved by controlling 
the temperature of inspired air.  This is the first report of a strategy in which 
thermoresponsive polymer platforms based on p(NIPAA) offering suitable mechanical 
properties have been designed as endotracheal tube biomaterials.   
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2. Materials and Methods 
2.1 Materials 
All chemicals were used as received, requiring no further purification.  2’,2’-Azobis-2-
methylpropionitrile 98% (AIBN) was purchased from Janssen Chimica, Beerse, Belgium and 
Labscan, Dublin, Ireland, respectively. Poly(ε-caprolactone) high molecular weight 50,000 
was a gift from Solvay Caprolactones, Warrington, England whereas Metronidazole, Acridine 
Orange, Rhodamine B base, N-isopropylacrylamide (NIPAA), Ethylene glycol dimethacrylate 
(EGDMA) and 2-Hydroxyethyl methacrylate (HEMA) were purchased from Sigma Aldrich Co., 
Dorset, England.  All other chemicals were purchased from BDH Laboratories, Poole, Dorset, 
England and were of AnalaR or equivalent grade. 
 
2.2 Materials Synthesis 
Poly(HEMA) was prepared by free radical polymerisation, as previously described by the 
authors [1, 27, 28].  Briefly, the required masses of monomer, initiator (AIBN 1% w/w), 
metronidazole (1% w/w, as a model drug) and crosslinker (EGDMA, 1% w/w) were mixed by 
stirring, then injected between two glass plates separated by silicone tubing spacer and 
release liner and heated at 90°C for one hour.  Preparation of poly(NIPAA) and copolymers 
of NIPAA and HEMA was similarly performed by free radical polymerisation by mixing the 
required masses of NIPAA (and when required HEMA), EGDMA (1% w/w), AIBN (1% w/w) 
and metronidazole (1% w/w) prior to polymerisation as described above.  Finally, the 
preparation of the semi-IPNs was performed according to a modification of the method 
described by Jones et al. [29].  In this poly(ε-caprolactone) (5.0g) was melted in the HEMA 
monomer (46.0g) with stirring at circa 50oC.  After cooling to approximately 30oC, ethylene 
glycol dimethacrylate (EGDMA, 1g), AIBN (1g), metronidazole (1g) and NIPAA (46.0g) were 
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mixed and the solution injected into glass moulds separated by silicone tubing spacer and 
release liner.  The system was maintained at 60oC for 1 hour to ensure homogeneous 
dispersion of the components and then polymerised at 90oC for one hour. 
 
2.3 Mechanical analysis 
Tensile analysis of hydrated polymer samples was performed using a Stable Micro Systems 
TA-XT2 Texture Analyser (Goldaming, Surrey, UK) interfaced with a personal computer.  
Initially the polymer samples were hydrated to equilibrium in phosphate buffered saline at 
pH7 and 20 ± 1oC.  Rectangular samples were cut from the swollen s-IPNs to dimensions of 
5cm by 1cm using a razor blade and accurately measured using digital Vernier callipers.  
Each sample strip was examined to ensure there were no jagged edges, before excess 
surface moisture was removed by gentle blotting with filter paper.  To protect the ends of 
the test sample from the metal grips, adhesive pads (Sellotape® “Sticky Fixers”) were applied 
to both sides of the ends, thus making the effective length of the sample 3cm.  Samples 
were loaded into position between the mobile upper and static lower clamps and checked 
for proper alignment before initiation of the test.  The upper clamp was raised at a fixed 
speed of 1.0 mm s-1 until fracture of the film occurred.    All analyses were performed at 20 ± 
1oC.  From the resultant force versus distance plot, the ultimate tensile strength, Young’s 
modulus and percentage elongation were calculated [29]. 
 
2.4 Determination of the swelling ratio 
Five 1cm2 replicates of the polymer samples under examination were initially dried, weighed 
accurately and transferred to McCartney bottles containing 25ml of buffer solution (pH 7 
phosphate buffered saline) at either 20°C or 37°C.  At specified times each sample was 
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removed, blotted dry between 2 pieces of filter paper (to remove excess surface buffer) and 
weighed.  The polymer samples were then returned to the buffer solution until the next time 
period.  
The swelling ratio (SR) was calculated using the equation below: 
 
 
Where: 
Wwet and Wdry refer to the weights of the sample when wet and dry (initial weight). 
 
2.5 Examination of the Thermal Properties of Selected Materials using Differential 
Scanning Calorimetry 
The thermal properties of selected s-IPNs and their parent hydrogels were examined using 
differential scanning calorimetry. In this, samples were placed in pans and hermetically 
sealed with a pinhole lid. Thermal analysis was performed using a TA Instruments MTDSC 
2920 (Leatherhead, Surrey), following calibration with Indium. A heating rate of 2oC min-1 
was applied over a temperature range of 20 to 180oC. In all cases at least quadruplicate 
measurements of the relationship between heat flow and temperature were determined.   
2.6 Confocal laser-scanning microscopy (CLSM) 
The physical natures of the s-IPNs were investigated using confocal laser-scanning 
microscopy (CLSM). A 1% w/v acridine orange (hydrophilic stain) aqueous solution was 
prepared by dissolving the stain (1.0g) in water (100ml).  Similarly, a 0.05% w/v solution of 
  
SR =
Wwet -Wdry
Wdry
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rhodamine B base (hydrophobic stain) was prepared by dissolving 0.05g of the stain in water 
(100ml).  The polymers were firstly stained with a drop of the individual dyes and examined 
using a Leica TCS SP2 confocal laser-scanning microscope, using a 10x objective.  For acridine 
orange, excitation of the sample was from the 488nm line of an Ar/ArKr laser, with detection 
between 498-574nm.  This acridine orange emission is shown in green in the micrographs 
(Figure 2 a and 2c).  For rhodamine B base, excitation of the sample was from the 543nm 
line of a GreNe laser, with detection between 565-650nm.  The rhodamine B base emission 
is shown in red in the micrographs (Figure 2b). 
 
The second part of the study involved preparing a mixed acridine orange/rhodamine B base 
stain by mixing equal volumes of these two solutions.  Acridine orange exclusively stained 
the hydrophilic hydrogel regions in the network whilst the hydrophobic rhodamine B base 
stained the PCL regions preferentially. Using line-by-line sequential scanning, images were 
obtained which allow the macro domains of both amorphous and crystalline PCL to be 
visualised simultaneously along with the interpenetrating channels of the hydrogel.  
 
2.7 Metronidazole release 
Samples of the drug loaded s-IPNs and parent hydrogels (10 x 10mm) were placed into a 
McCartney bottle containing 30ml buffer solution of the required pH and placed into a 
shaking water bath at either 20oC or 37oC and 60 shakes min-1.  Sink conditions were 
maintained under these conditions.  At specified time points, the polymer samples were 
transferred to another McCartney bottle containing 10ml buffer solution while the original 
sample medium was analysed at 320nm using UV spectrophotometry.  The mass of 
metronidazole in the samples of dissolution media was calculated by reference to a freshly 
prepared calibration curve prepared in the buffer system (r > 0.99). 
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2.8 Statistical Analysis 
For tensile analysis, the effect of hydrogel composition and PCL concentration on the 
ultimate tensile strength, Young’s modulus, percentage elongation and thermal properties 
were statistically evaluated using a two-way Analysis of Variance (ANOVA).  A two-way 
ANOVA was used to statistically analyse the effects of film composition and temperature on 
the swelling ratio.  Similarly, for the drug release experiments, a two-way repeated 
measures ANOVA was used to statistically analyse the effects of film composition and 
temperature on drug release.  Post-hoc comparisons of the means of individual results were 
performed using the Neuman-Keuls test and in all cases p<0.05 denoted significance [30]. 
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3. Results 
The mechanical properties of the various platforms under investigation are presented in 
table one.  As may be observed the mechanical properties (ultimate tensile strength, 
percentage elongation and Young’s modulus) were affected by both the composition of the 
hydrogel component of the network and the concentration of PCL. The mechanical 
properties of the networks were dependent on the composition of the parent hydrogel 
platform.  Increasing the ratio of HEMA to NIPAA significantly increased the ultimate tensile 
strength and Young’s modulus but decreased the percentage elongation at break.  
Increasing the PCL content within the network sequentially increased the ultimate tensile 
strength and Young’s modulus but decreased the % elongation at break of these materials.  
Importantly, whilst the incorporation of PCL significantly decreased the % elongation at 
break of the various hydrogels, these systems still retained useful elongation properties.   
Furthermore, whilst the mechanical properties of the poly(NIPAA) hydrogel were limited, 
the incorporation of PCL rendered these systems more suitable for clinical use.  
Determination of the mechanical properties of the materials under investigation at 
temperatures above the lower critical solution temperature (37oC) was not quantitatively 
performed due to the irregular dimensions of the samples.  However qualitatively the sIPNs 
exhibited ultimate tensile strength values that were both considerable and consistent with 
those of the materials when measured below the lower critical solution temperature. 
 
Table two illustrates the effect of network composition and temperature of the bathing 
medium (pH 7, phosphate buffered saline) on the equilibrium-swelling ratio of the various 
networks under investigation.  As may be observed both the composition of the network 
and temperature significantly affected the equilibrium-swelling ratio.  Thermoresponsive 
behaviour was noted for all NIPAA containing hydrogels, both in the absence and presence 
of PCL, whereas, as expected, poly(HEMA) hydrogels either containing or devoid of PCL did 
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not show thermoresponsive swelling behaviour.  These results explained the significant 
interaction component that was observed in the ANOVA.  The temperature dependency of 
the poly(NIPAA) hydrogels was most pronounced.  The swelling properties of the hydrogel 
co-polymer systems containing 1-20% w/w PCL were similar.  Accordingly in such systems, 
increasing the mass of PCL did not affect the equilibrium swelling properties and, 
importantly, enabled these systems to offer thermoresponsive behaviour.  In poly(NIPAA) 
based hydrogel systems the incorporation of PCL significantly lowered the equilibrium 
swelling ratio at 20oC in a concentration-dependent manner, however, it is important to 
note that even in the presence of 20% w/w PCL, these systems retained their 
thermoresponsive properties and showed a circa 5 fold swelling at 20oC.   
 
The release of a model drug, metronidazole, expressed as the times for 10%, 30% and 50% 
of the original mass of metronidazole to be released, from the various network systems, at 
either 20oC or 37oC under sink conditions (into pH 7.4 buffer) is shown in table three.  
Furthermore, the release profiles of metronidazole from exemplar networks are shown in 
Figure one. In addition, the release of metronidazole from the aforementioned systems was 
modelled according to the generalised power law model [31] (table four).  In the absence of 
PCL the release exponents of poly(HEMA) hydrogels were 0.64 ± 0.02 and 0.66 ± 0.04 at 20oC 
and 37oC, respectively.  Similarly the release exponent of poly(NIPAA) at 20oC was 0.65 ± 
0.30 however the rapid release resulting from the thermoresponsive nature of this material 
did not enable measurement of the release exponent.  In the presence of PCL (at either 10 
or 20% w/w), the release exponents of the co-polymer s-IPNs were statistically similar to 0.5 
from which it may be inferred that diffusion controlled released occurred.  Furthermore, the 
release exponent of metronidazole was unaffected by increasing PCL concentration.  PCL 
containing poly(NIPAA) s-IPNs exhibited diffusion controlled release at 20oC but at 37oC, the 
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thermoresponsive release of metronidazole from these systems rendered this measurement 
impossible.  
 
Regarding the release kinetics, increasing the concentration of PCL significantly increased 
the times required for 10, 30 and 50% release of metronidazole at both 20oC and 37oC for 
systems based on poly(HEMA) and poly(HEMA-co-NIPAA).  In these systems, the times 
required for the release of a known percentage of metronidazole were similar at 20oC and 
37oC.  Importantly, the network systems composed of poly(NIPAA) and PCL (either 10 or 20% 
w/w) displayed thermoresponsive drug release, the release at 20oC being sustained and 
diffusion controlled whereas, in comparison, drug release at the higher temperature was  
comparatively rapid.   
 
Confocal laser scanning micrographs of s-IPN composed of poly(NIPAA) and PCL (10% w/w) 
that had been stained with acridine orange, rhodamine B or concurrently with both dyes are 
presented in Figure 2a, b and c, respectively.  In these micrographs the hydrophilic and 
hydrophobic regions are stained green and red, respectively.  The two dyes fluoresced 
independently of each other. In figure 2c the hydrophilic and hydrophobic domains were 
stained simultaneously, illustrating the biphasic distribution of the s-IPN.   
 
The effect of network composition on the thermal behaviour of selected networks is shown 
in table 5.  In the absence of PCL, poly(NIPAA) and poly(NIPAA-co-HEMA, 1:1 ratio) exhibited 
endotherms at  31.51 ± 1.52oC and 142.04 ± 2.02oC for p(NIPAA) and at 34.87 ± 1.02oC and 
130.05 ± 1.83 oC for p(NIPAA-co-HEMA).  The lower endotherm is indicative of the lower 
critical solution temperature whereas the higher endotherm reflects a glass transition 
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temperature.  Hydrogel composition significantly affected the glass transition and lower 
critical solution  temperatures.  Incorporation of PCL (20% w/w) did not significantly affect 
the temperature at which either transition occurred however, in these systems a third 
endotherm was noted at circa 59oC, the position of which was unaffected by the chemical 
composition of the hydrogel network and may be attributed to the melt endotherm of 
dispersed PCL.  
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4. Discussion 
As a result of their limited mechanical properties, the clinical use of hydrogels has been 
restricted to certain (defined) applications e.g. contact lenses, soft tissue implants, 
constructs for tissue engineering and coatings for medical devices [8, 23].  In addition to 
their use as medical implants/devices, hydrogels have found extensive use as drug delivery 
systems in which drug release may be diffusion controlled or facilitated by an external 
stimulus, e.g. pH, temperature [32-34].  Whilst other polymeric candidates have been 
examined as platforms for thermoresponsive drug delivery, e.g. poloxamers [35, 36], the 
majority of thermoresponsive drug delivery platforms have involved poly(NIPAA) or co-
polymers of this monomer with other acrylate monomers [37-41].  Although the ability to 
poly(NIPAA)-based polymers to offer stimuli sensitive release has been recognised, one of 
the main limitations associated with the use of these systems as bioactive implants is their 
sub-optimal mechanical properties [23, 42]. To enhance their mechanical properties (and 
hence augment their clinical applications), copolymerisation with other monomers, e.g. 
acrylic acid, methacrylic acid and methacrylic acid esters or the addition of cross-linkers have 
been reported [19, 43, 44].  However, there are limitations with these approaches including, 
reductions in the equilibrium water content and deleterious effects on the 
thermoresponsive behaviour.  Therefore, there is a pharmaceutical need to develop 
platforms that offer both thermoresponsive behaviour and whose mechanical properties are 
robust and may be engineered to meet specific clinical demands.  Uniquely, this study 
reports a platform technology that addresses these issues, thereby enhancing the scope of 
applications for which p(NIPAA) based polymers may be used.  This is the first report of the 
use of thermoresponsive materials designed for use as bioactive endotracheal tubes for the 
prevention of ventilator associated pneumonia. 
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The platforms described in this study were prepared by dispersion of molten PCL within the 
liquid monomer/crosslinker mixture, followed by free radical polymerisation.  In a previous 
study, the authors confirmed that when polymerised in this manner, HEMA and NIPAA form 
a copolymer [19].  The composition of the hydrogel networks in this study was shown to 
affect the physicochemical performance of the networks.  Examination of the thermal 
properties of the PCL-containing s-IPNs under examination revealed a melt endotherm (at 
circa 59oC), which was statistically similar to the melt temperature of PCL [45, 46], 
confirming the existence of PCL as a disperse phase within the hydrogel matrix. In addition, 
two thermal (glass) transitions were observed that may be accredited to p(NIPAA) (142.04 ± 
2.02°C) and p(HEMA-co-NIPAA) (130.05 ± 1.83°C) [19], the magnitudes of which were 
unaffected by the presence of PCL.  The presence of PCL as a disperse phase within the 
hydrogel platforms was further confirmed using confocal laser scanning microscopy, in 
conjunction with the use of dyes that selectively stained the hydrophilic (acridine orange) 
and hydrophobic areas (rhodamine B) of the platforms.  As may be observed from figure two 
the dyes allowed visualisation of these discrete domains, providing further evidence of the 
disperse nature of PCL within the hydrogel.  Interestingly this is one of the few reports that 
have involved the use of confocal laser scanning microscopy (with two stain specific dyes) to 
visualise the physical structure of polymer blends.  
 
Typically, the mechanical properties of poly(HEMA) networks exceeded those of the (HEMA: 
NIPAA) copolymer and poly(NIPAA), the properties of poly(NIPAA) being unsuitable for 
clinical application as an implant or as a medical device biomaterial, where the ability to 
insert and removal the material is important.  Despite the incorporation of a crosslinker 
(EGDMA), the inappropriate mechanical properties of poly(NIPAA) systems suggested that 
the number and/or strength of interchain interactions between adjacent poly(NIPAA) chains 
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were lower than those between adjacent chains of poly(NIPAA-co-HEMA) and poly(NIPAA).   
The lower Young's modulus and higher % elongation at break illustrates the greater ability of 
poly(NIPAA) and the copolymer to undergo plastic deformation, highlighting the lower 
elasticity of these systems.  Accordingly in situations where the maintenance of the shape of 
the drug delivery system is important, e.g. as an implant/insert, hydrogels based on 
p(NIPAA) would be unsuitable.  Incorporation of PCL (in a concentration-dependent fashion) 
within the hydrogel matrix significantly enhanced the elastic properties of the various 
networks, these observations being accredited to the presence of PCL as a disperse, solid 
phase acting as a filler [47].  Of particular interest are the dramatic enhancements of the 
ultimate tensile strength and Young's modulus of p(NIPAA) hydrogels in the presence of 10 
or 20% w/w PCL, properties that would be suitable for use for applications in which the 
mechanical properties are essential to the use of the product.  In addition, the increase in 
the ultimate tensile strength and Young's modulus of these materials was not associated 
with a compromised percentage elongation at break.   It is proposed that that materials 
described in this study would offer particular promise as endotracheal tube biomaterials in 
which drug loading may be performed by nebulisation of an antimicrobial solution at 
temperatures below the lower critical solution temperature and drug release may be 
subsequently initiated by the inspiration of warm air at temperatures exceeding the lower 
critical solution temperature.  To evaluate the mechanical properties of the materials it is 
appropriate to compare the said properties to those of endotracheal polyvinyl chloride 
(PVC).  In a previous publication [48], the physicochemical properties of endotracheal tube 
PVC both containing and devoid of drug were characterised. Typically the ultimate tensile 
strength, % elongation at break and Young’s modulus of PVC were 2.89±0.00 MPa, 
285.93±10.28 and 1.12± 0.05MPa, respectively, which, following incorporation of drug (1%, 
akin to this study) were modified to 1.28±0.00MPa, 114.71±5.28 and 1.15±0.08MPa, 
respectively.  The mechanical properties of the sIPNs described in this study were 
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comparable to endotracheal tube PVC and indeed, in some instances the resistance of the 
sIPNs to fracture was greater than that of PVC.  With the exception of certain drug 
containing sIPNs (50:50 HEMA:NIPAA containing 1, 5 and 10% PCL), the elongation at break 
of the sIPNs was generally lower than that of PVC, however, as patients who use these 
medical devices are immobile, the reduction in magnitude of this parameter would not 
cause a concern clinically.  The elasticity of the s-IPN would be sufficient to resist 
deformation in use and to facilitate insertion into the trachea without damaging the 
respiratory tract.  Furthermore, the ultimate tensile strength of these s-IPNs are sufficient to 
prevent fracture during insertion and in situ.  Accordingly, it is suggested that the 
mechanical properties of the s-IPNs described in this study would be sufficient to allow their 
application as endotracheal tube biomaterials in their own right. 
 
In this study the equilibrium swelling ratios of the networks were examined as functions of 
temperature and composition and illustrated the effects of hydrogel composition and PCL 
loading on this parameter.  Increasing the PCL content significantly lowered the equilibrium-
swelling ratio at 25oC and (in general) at 37oC.  These observations may be accredited to the 
reduction in the (hydrophilic) hydrogel component within the network and the subsequent 
reduction in free hydrogel volume.  A disparity in the equilibrium swelling ratios at 25oC and 
37oC was observed in polymer networks composed of NIPAA or NIPAA: HEMA copolymers in 
which the equilibrium-swelling ratio of 25oC was significantly greater than that at 37oC.  
Furthermore, the equilibrium swelling properties of poly(NIPAA) systems were markedly 
greater than those of comparator systems composed of poly(HEMA-co-NIPAA) at 25oC 
although the differences were not apparent at the higher temperature.  Following thermal 
characterisation, the lower critical solution temperatures of the p(NIPAA-co-HEMA) and 
p(NIPAA) matrices (both in the presence and absence of PCL)  were circa 34oC and 32oC, 
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respectively.  Accordingly, the equilibrium-swelling ratios reflect the swelling below and 
above the lower critical solution temperature.  The temperature independent equilibrium 
swelling ratios of poly(HEMA) and PCL containing poly(HEMA) confirm the non-thermally 
responsive properties of these systems.   The presence of PCL decreased the equilibrium-
swelling ratio of systems composed of poly(NIPAA) and poly(NIPAA-co-HEMA), however the 
most dramatic effect on this parameter was associated with the poly(NIPAA)/PCL (20%w/w) 
s-IPN.  The significance of these observations is two-fold.  Firstly, where drug loading is 
facilitated by immersion of the xerogel into a saturated drug solution, materials that exhibit 
the greatest equilibrium-swelling ratio will also exhibit the greatest drug loading.  Secondly, 
the polymeric systems that exhibit the greatest reduction in equilibrium swelling ratio would 
be expected to offer thermoresponsive drug release.  Again of great interest to the aim of 
this study is the pronounced thermoresponsive properties of poly(NIPAA) platforms 
containing PCL (10 or 20% w/w).  The incorporation of PCL significantly lowered the 
thermoresponsive response however the magnitude of this reduction was small.  Typically 
there was a ten-fold reduction in the volume of these systems below and above the LCST), 
even in the presence of PCL.  Accordingly, in addition to the improved mechanical properties 
of these systems resultant from the inclusion of PCL, maintenance of pronounced 
thermoresponsive properties was observed.   
 
Examination of the drug release properties of the various polymer platforms under 
investigation revealed interesting observations regarding the effects of temperature induced 
volume changes on this parameter.  As expected, PCL containing poly(HEMA) s-IPNs did not 
exhibit thermoresponsive drug release.  However, whilst not thermoresponsive, the release 
of drug from these systems was controlled and prolonged, with typically circa 70% of the 
drug payload being released over a 10 hour period.  Typically the release of water soluble 
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drugs (e.g. metronidazole) from p(HEMA) is rapid and uncontrolled [1].  Accordingly, these 
systems, whilst not applicable for this chosen application, may offer opportunities for other 
medical devices, e.g. intravaginal drug-containing implants.  PCL containing poly(NIPAA) s-
IPNs exhibited pronounced thermoresponsive release of metronidazole.  Interestingly, PCL 
containing poly(HEMA-co-NIPAA) platforms, despite illustrating temperature-dependent 
changes in volume, did not exhibit thermoresponsive release of metronidazole, illustrated by 
statistically similar t10%, t30% and t50% values.  Following application of the generalised release 
model [49], the release exponents for all PCL containing poly(HEMA-co-NIPAA) platforms 
were circa 0.5, at each temperature, inferring diffusion (not thermoresponsive) drug release 
occurred in these systems.  It may be therefore inferred that the reduction in volume of 
these platforms was insufficient to release the drug in a pulsatile fashion or alternatively, the 
temperature induced rheological (sol-gel) changes occurred prior to the commencement of 
drug transport.  As a result, despite the mechanical improvements offered by the 
incorporation of PCL within the hydrogel copolymers, these systems do not offer 
thermoresponsive functionality thereby negating their use as thermoresponsive drug 
delivery implants.  It is important to note the thermoresponsive behaviour of the PCL 
containing poly(NIPAA) platforms.  In this the entire drug payload was released within 1h, 
despite the enhancement of the structure due to the presence of the dispersed hydrophobic 
phase. 
As defined previously the systems described in this manuscript are designed for use as 
bioactive endotracheal tubes, their mechanical properties being sufficient to enable their 
use as the sole constituent of the endotracheal tube (i.e. no coating technologies are 
required).  Ventilator associated pneumonia is frequently associated with the use of 
endotracheal tubes and then has been itself shown to be due to biofilm on the luminal 
surface of the endotracheal tube [26].  Strategies for the prevention/treatment of ventilator-
associated pneumonia are therefore targeted at the removal of the microbial biofilm.  Whilst 
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in the biofilm, the resistance of microorganisms to antimicrobial agents is markedly 
increased (up to 1000 fold increase) [50].  Associated with this problem is the inability to 
achieve sufficiently high concentrations of antimicrobial agent at the luminal surface of the 
device.  Therefore alternative strategies have been developed to address these issues 
including the use of bioactive endotracheal tubes [51, 52] and the direct nebulization of 
antimicrobial surfaces across the luminal surfaces of the device and into the lungs [53].  
Typically there is a limited volume of fluid at the luminal surface, therefore presenting a 
thermodynamic resistance to drug diffusion from the bioactive device.  The strategy 
described in this manuscript has successfully addressed this concern; the associated volume 
change due to changes in the environmental temperature effectively mechanically driving 
the drug solution from the polymeric network.  Akin to traditional strategies for the 
treatment of infection, a pulsed released of drug offers is preferred to achieve the highest 
concentration at the site of action and hence achieve the greatest kill kinetics.  Therefore, 
the observed pulsed release in which the drug load was effectively released over a short 
period is optimal for the prevention/treatment of ventilator-associated pneumonia.  Key to 
the function of these systems within the clinical environment is the control of temperature 
within the environment of the endotracheal tube.  This may be readily controlled in a 
number of ways.  Firstly, loading of the drug may be achieved by nebulization of an 
antimicrobial solution at a temperature below the lower critical solution temperature of the 
polymer platform; the swelling of the polymer will enable an effective uptake of the solution 
within the network.  Maintenance of this temperature within the respiratory tract may be 
performed by controlling the temperature of the inspired air.  Under which conditions drug 
release will not occur due to the thermodynamic restraints imposed by the system due to 
the limited volume of fluid adjacent to the luminal surface of the device.  When required the 
temperature of the inspired air may be elevated temporarily to ensure that the temperature 
of the air surrounding the device exceeds the lower critical solution temperature of the 
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polymer network.  Under these conditions, drug release will be facilitated by a change in the 
volume of the polymer network, a process that is not dependent on diffusion.  This ability to 
offer pulsatile drug release that is modulated by the temperature of the inspired air is 
suggested to be particular applicable for the improved treatment/prevention of ventilator 
associated pneumonia. 
 
  
  
 23 
5. Conclusions 
This study describes the design of thermoresponsive semi-interpenetrating polymer 
networks based on crosslinked poly(NIPAA) or poly(NIPAA-co-HEMA) hydrogels containing 
poly(ε-caprolactone) that are designed for use as endotracheal tube biomaterials.  The lower 
critical solution temperature of the co-polymer and poly(NIPAA) matrices were circa 34oC 
and 32oC, respectively, confirming the thermoresponsive behaviour of these systems at 
physiological temperatures.  PCL was physically dispersed within the hydrogel matrices as 
confirmed using confocal laser scanning microscopy and differential scanning calorimetry.  
The elastic properties of poly(NIPAA) hydrogels were lower than comparator hydrogels 
composed of poly(NIPAA-co-HEMA) or poly(HEMA).  Incorporation of PCL significantly and 
markedly increased these elastic properties and rendered poly(NIPAA) systems suitable for 
use as implantable materials.  Poly(NIPAA) containing s-IPNs exhibited thermoresponsive 
swelling following immersion in an aqueous phase, with the equilibrium-swelling ratio being 
greater at 20oC than 37oC and greatest for poly(NIPAA)/PCL s-IPNs at 20oC.  The 
incorporation of PCL significantly lowered the equilibrium swelling ratio of poly(NIPAA) at 
20oC.  Thermoresponsive release of metronidazole was observed from s-IPNs composed of 
poly(NIPAA)/PCL at 37oC but not from s-IPNs composed of poly(NIPAA-co-HEMA)/PCL at this 
temperature.  In all other platforms drug release at 20oC was significantly similar to that at 
37oC and was diffusion controlled.  In conclusion, the biomaterials described in this study 
exhibited combined properties of enhanced mechanical properties (ultimate tensile 
strength, % elongation at break and the Young’s Modulus) and the thermoresponsive 
release of a model hydrophilic antimicrobial drug.  The mechanical properties of these 
materials would ensure the necessary ease of insertion without undue damage to the 
respiratory mucosa and rigidity in use, the latter facilitation patency of airflow, the key 
physiological demand of endotracheal tubes.  Due to the thermoresponsive properties of the 
biomaterials, drug loading may be performed by nebulising an antimicrobial solution at a 
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temperature below the lower critical solution temperature of the polymer network.  Drug 
release may then be activated by increasing the temperature of the inspired air above the 
lower critical solution temperature, the rapid release of a high concentration of drug 
offering the optimum opportunity to resolve the microbial biofilm on the luminal surface of 
the endotracheal tube.  It is suggested that the biomaterials described in this study offer a 
novel strategy for the prevention/treatment of ventilator-associated pneumonia.  
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Table One. The effect of polymer composition on the mechanical properties of 
hydrogels and hydrogel-PCL semi-interpenetrating polymer networks 
 
Monomer 
Ratio (HEMA: 
NIPPA) 
 
Mass of PCL 
(% w/w) 
Mean (± sd) Mechanical Properties: 
Ultimate Tensile 
Strength (MPa) 
% Elongation 
at Break (%) 
Young’s 
Modulus 
(MPa) 
100:0 0 0.34 ± 0.03 60.61 ± 5.28 1.15 ± 0.05 
0:100 0 0.01 ± 0.00 139.00 ± 2.05 0.04 ± 0.01 
50:50 0 0.29 ± 0.02 123.95 ± 5.03 0.07 ± 0.01 
50:50 1 1.01 ± 0.05 120.05 ± 6.00 0.07 ± 0.01 
50:50 5 2.23 ± 0.14 120.01 ± 3.76 0.15 ± 0.00 
50:50 10 8.64 ± 0.65 100.92 ± 6.04 0.23 ± 0.01 
50:50 20 10.78 ± 0.88 58.02 ± 3.85 1.34 ± 0.10 
0:100 10 6.05 ± 0.31 41.03 ± 3.75 1.42 ± 0.25 
0:100 20 9.02 ± 0.72 60.32 ± 4.02 2.05 ± 0.36 
100:0 10 9.94 ± 0.74 45.03 ± 3.05 1.65 ± 0.02 
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Table Two. The effect of polymer composition and temperature on the 
equilibrium swelling ratio of hydrogels and hydrogel-PCL semi-
interpenetrating polymer networks at pH 7 
Ratio of HEMA: 
NIPAA 
Concentration of PCL 
(%w/w) 
Mean (± sd) Equilibrium Swelling Ratio of 
Networks in pH 7 buffer at: 
20°C 37°C 
100:0 0 0.62±0.03 0.63±0.05 
0:100 0 7.39±0.36 0.40±0.03 
50:50 1 1.13±0.09 0.44±0.05 
50:50 5 1.01±0.03 0.39±0.02 
50:50 10 0.99±0.04 0.35±0.01 
50:50 20 0.80±0.03 0.32±0.01 
100:0 10 0.50±0.03 0.48±0.02 
0:100 10 6.93±0.45 0.52±0.02 
0:100 20 5.58±0.28 0.40±0.02 
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Table Three. The effect of polymer composition and temperature of the dissolution 
medium (pH 7.4) on the time required to release a defined % of the 
original drug loading from hydrogels and hydrogel-PCL semi-
interpenetrating polymer networks 
 Time required to release a defined % of the 
original mass of loaded drug (min) 
Conc. of 
PCL (%) 
Ratio of 
HEMA: NIPAA 
Temp 
(oC)  
Time 10% Time 30% Time 50% 
1 50:50 20 20.99 ± 1.22 66.2 ± 3.11 163.88 ± 10.21 
5 50:50 20 22.53 ± 1.80 75.94 ± 5.13 193.16 ± 15.51 
10 50:50 20 25.18 ± 1.79 92.57 ± 6.24 241.82 ± 16.24 
20 50:50 20 27.27 ± 2.01 105.7 ± 7.56 283.59 ± 15.45 
1 50:50 37 21.38 ± 1.62 68.71 ± 3.84 168.65 ± 13.41 
5 50:50 37 23.15 ± 1.40 79.81 ± 4.51 204.43 ± 14.74 
10 50:50 37 25.51 ± 1.49 94.66 ± 8.65 248.48 ± 12.41 
20 50:50 37 27.79 ± 2.14 109.02±15.43 294.15 ± 16.45 
10 0:100 20 25.79 ± 1.74 96.41 ± 7.45 254.38 ± 12.45 
10 0:100 37 6.49 ± 0.34 19.46 ± 1.24 34.43 ± 2.41 
20 100:0 20 25.47 ± 1.20 98.27 ± 6.41 247.79 ± 13.47 
20 100:0 37 26.40 ± 1.69 104.83 ± 7.12 262.43 ± 13.49 
20 0:100 20 8.95 ± 0.45 120.01 ± 7.42 279.02 ± 10.04 
20 0:100 37 7.92 ± 0.38 22.02 ± 1.00 40.04 ± 2.04 
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Table Four. The effect of polymer composition and temperature on release 
exponent of metronidazole from semi-interpenetrating polymer 
networks 
Network Composition Mean (± sd) release exponent at (oC) 
PCL Concn (%w/w) Ratio of HEMA: 
NIPAA 
20oC 37oC 
0 100:0 0.64 ± 0.02 0.66 ± 0.04 
0 0:100 0.65 ± 0.03 - 
1 50:50 0.47 ± 0.03 0.48 ± 0.02 
5 50:50 0.47 ± 0.03 0.47 ± 0.03 
10 50:50 0.46 ± 0.03 0.47 ± 0.03 
20 50:50 0.48 ± 0.03 0.48 ± 0.03 
10 100:0 0.47 ± 0.03 0.48 ± 0.03 
10 0:100 0.49 ± 0.03 - 
20 0:100 0.50 ± 0.02 - 
- Release exponent could not be measured due to thermoresponsive release 
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Table Five. The thermal properties of sequential interpenetrating polymer 
networks 
Ratio of NIPAA: 
HEMA 
Concentration of 
PCL (%w/w) 
Endotherm 1 (oC)a Endotherm 2 
(oC)b 
Endotherm 3 
(oC)b 
100:0 0 31.51 ± 1.52 142.04 ± 2.02 ND 
100:0 20 31.49 ± 1.23 141.95 ± 2.06 58.05 ± 2.01 
50:50 0 34.87 ± 1.02 130.05 ± 1.83 ND 
50:50 20 35.23 ± 0.85 131.83 ± 1.63 58.95 ± 2.84 
ND Not Determined 
a Sol-gel transition temperature 
b Glass transition temperature 
c Melting endotherm of PCL 
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Figure 1. The release of metronidazole from semi-interpenetrating polymer networks 
composed of PCL (10% w/w) and p(NIPAA, circles), p(NIPAA-co-HEMA, triangles) 
or p(HEMA, squares) at 20oC (closed symbols) and 37oC (open symbols) 
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Figure 2. Confocal laser scanning micrographs showing a model semi-
interpenetrating polymer network based on p(HEMA-co-NIPAA) and  
10% w/w PCL: (a) stained with acridine orange, (b) stained with 
rhodamine B, (c) simultaneously stained with both acridine orange 
and rhodamine B 
Figure 2 (a) 
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Figure 2 (b) 
 
 
Figure 2 (c) 
 
 
  
